BBVA USA Bancshares’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
$2.37M Sell
31,475
-202
-0.6% -$14.7K 0.11% 178
2020
Q4
$2.16M Buy
31,677
+334
+1% +$21.7K 0.11% 173
2020
Q3
$1.9M Sell
31,343
-1,524
-5% -$94.8K 0.11% 168
2020
Q2
$2.14M Sell
32,867
-1,784
-5% -$112K 0.13% 157
2020
Q1
$2.06M Sell
34,651
-723
-2% -$48.3K 0.15% 139
2019
Q4
$2.63M Sell
35,374
-3,456
-9% -$243K 0.15% 139
2019
Q3
$2.45M Sell
38,830
-4,044
-9% -$240K 0.16% 145
2019
Q2
$2.34M Sell
42,874
-35,208
-45% -$1.9M 0.14% 147
2019
Q1
$4.21M Sell
78,082
-16,355
-17% -$1.01M 0.26% 94
2018
Q4
$6.19M Buy
94,437
+49,265
+109% +$3.68M 0.44% 56
2018
Q3
$3.56M Buy
45,172
+6,373
+16% +$456K 0.21% 111
2018
Q2
$2.5M Sell
38,799
-2,352
-6% -$155K 0.16% 141
2018
Q1
$2.56M Sell
41,151
-4,145
-9% -$297K 0.17% 136
2017
Q4
$3.28M Sell
45,296
-2,189
-5% -$159K 0.21% 108
2017
Q3
$3.86M Sell
47,485
-4,022
-8% -$318K 0.25% 92
2017
Q2
$4.14M Sell
51,507
-2,029
-4% -$160K 0.27% 90
2017
Q1
$4.2M Sell
53,536
-2,141
-4% -$171K 0.28% 94
2016
Q4
$4.39M Sell
55,677
-2,113
-4% -$171K 0.31% 79
2016
Q3
$5.14M Sell
57,790
-259
-0.4% -$24.4K 0.37% 70
2016
Q2
$5.56M Sell
58,049
-6,473
-10% -$645K 0.42% 63
2016
Q1
$6.69M Sell
64,522
-6,455
-9% -$628K 0.5% 49
2015
Q4
$6.94M Sell
70,977
-3,702
-5% -$363K 0.52% 48
2015
Q3
$7.21M Sell
74,679
-5,242
-7% -$551K 0.56% 43
2015
Q2
$8.38M Sell
79,921
-6,260
-7% -$640K 0.47% 66
2015
Q1
$8.89M Sell
86,181
-6,242
-7% -$632K 0.4% 81
2014
Q4
$8.9M Sell
92,423
-8,217
-8% -$724K 0.4% 76
2014
Q3
$8.01M Buy
100,640
+12
+0% +$946 0.36% 95
2014
Q2
$7.58M Buy
100,628
+3,038
+3% +$230K 0.33% 104
2014
Q1
$7.31M Sell
97,590
-26,956
-22% -$1.9M 0.33% 105
2013
Q4
$8.91M Buy
124,546
+2,138
+2% +$137K 0.39% 79
2013
Q3
$6.95M Buy
122,408
+3,653
+3% +$218K 0.33% 100
2013
Q2
$6.79M Buy
+118,755
New +$6.88M 0.34% 88

Other funds holding CVS

BBVA USA Bancshares's CVS Position: Q1 2021 in Review

BBVA USA Bancshares reduced its CVS Health (CVS) stake by 0.64% in Q1 2021, selling an estimated $14.7K and leaving 31,475 shares worth $2.37M. The position accounts for 0.11% of the portfolio, ranked #178.

BBVA USA Bancshares first reported a position in CVS in Q2 2013 and has held it in 32 quarters since. The position peaked at $8.91M in Q4 2013. 2,033 funds tracked by Wall St. Rank hold CVS as of Q1 2021.

  • BBVA USA Bancshares held 31,475 shares of CVS Health worth $2.37M as of Q1 2021.
  • BBVA USA Bancshares sold 202 CVS Health shares in Q1 2021, an estimated $14.7K.
  • CVS Health made up 0.11% of BBVA USA Bancshares's portfolio in Q1 2021, its #178 holding.
  • BBVA USA Bancshares first reported a position in CVS Health in Q2 2013 and has held it in 32 quarters since.
  • BBVA USA Bancshares's CVS Health position peaked at $8.91M in Q4 2013.
  • 2,033 funds tracked by Wall St. Rank held CVS Health as of Q1 2021.

Based on BBVA USA Bancshares's 13F filing for Q1 2021, filed 23 Apr 2021.